Genome-wide expression profiling of B lymphocytes reveals IL4R increase in allergic asthma - 02/10/14
Doi : 10.1016/j.jaci.2014.05.015
Marien Pascual, PhD a 
, Sergio Roa, PhD a , Asunción García-Sánchez, PhD b, c, Catalina Sanz, PhD c, d, Laura Hernandez-Hernandez, PhD c, John M. Greally, MD, PhD e, Félix Lorente, MD, PhD b, c, f, Ignacio Dávila, MD, PhD b, c, g, María Isidoro-García, MD, PhD c, h, i
, Sergio Roa, PhD a , Asunción García-Sánchez, PhD b, c, Catalina Sanz, PhD c, d, Laura Hernandez-Hernandez, PhD c, John M. Greally, MD, PhD e, Félix Lorente, MD, PhD b, c, f, Ignacio Dávila, MD, PhD b, c, g, María Isidoro-García, MD, PhD c, h, i a Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain
b Department of Pediatrics, University of Salamanca, Salamanca, Spain
c Instituto Biosanitario de Salamanca (IBSAL), Salamanca, Spain
d Department of Microbiology and Genetics, University of Salamanca, Salamanca, Spain
e Division of Computational Genetics, Department of Genetics, Center for Epigenomics, Albert Einstein College of Medicine, Bronx, NY
f Servicio de Pediatría, Hospital Universitario de Salamanca, Salamanca, Spain
g Servicio de Inmunoalergia, Hospital Universitario de Salamanca, Salamanca, Spain
h Servicio de Bioquímica Clínica, Hospital Universitario de Salamanca, Salamanca, Spain
i Department of Medicine, University of Salamanca, Salamanca, Spain
| This study was supported by a grant from the Spanish Ministry of Health (FIS - Fondo de Investigación Sanitaria, grant no. PI10/01706, Instituto de Salud Carlos III), cofinanced with FEDER - Fondo Europeo de Desarrollo Regional funds, and the funding of the Spanish Society of Allergology and Clinical Immunology. This research was also supported by a Sara Borrell Fellowship (grant no. CD12/00540 to M.P.), a Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme (grant no. PIIF/GA/2012/328177 to S.R.), and a Fundación Botín-Universidad de Salamanca Fellowship (to A.G.-S.). |
|
| Disclosure of potential conflict of interest: M. Pascual has received research support from the Sara Borrell Fellowship. S. Roa has received research support from the Marie Curie International Incoming Fellowship. A. García-Sánchez has received research support from the Fundacion Botin-Universidad de Salamanca. C. Sanz and I. Dávila have received research support from the Spanish Society of Allergology and Clinical Immunology. J. M. Greally has received research support from the National Institutes of Health, United States. F. Lorente and M. Isidoro-García have received research support from the FIS - Instituto de Salud Carlos III, the FEDER funds, and the Spanish Society of Allergology and Clinical Immunology. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2014
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 134 - N° 4
P. 972-975 - octobre 2014 Retour au numéro
Article précédent
- Systemic and localized seminal plasma hypersensitivity patients exhibit divergent immunologic characteristics
- Debajyoti Ghosh, Jonathan A. Bernstein
- TNF-?/IL-17 synergy inhibits IL-13 bioactivity via IL-13R?2 induction
- Vahe Badalyan, Robert Thompson, Kezia Addo, Lee A. Borthwick, Andrew J. Fisher, Tatiana Ort, Timothy G. Myers, Thomas A. Wynn, Thirumalai R. Ramalingam
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?